WAFIK ZAKY to Brain Neoplasms
This is a "connection" page, showing publications WAFIK ZAKY has written about Brain Neoplasms.
Connection Strength
1.438
-
Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy. Pediatr Blood Cancer. 2019 12; 66(12):e27974.
Score: 0.213
-
Ganglioglioma in children and young adults: single institution experience and review of the literature. J Neurooncol. 2018 Sep; 139(3):739-747.
Score: 0.195
-
The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities. Cancer Metastasis Rev. 2017 12; 36(4):617-633.
Score: 0.188
-
Primary intracranial soft tissue sarcomas in children, adolescents, and young adults: single institution experience and review of the literature. J Neurooncol. 2016 Mar; 127(1):155-63.
Score: 0.165
-
Choroid plexus carcinoma in children: the Head Start experience. Pediatr Blood Cancer. 2015 May; 62(5):784-9.
Score: 0.155
-
Prognostic factors for pediatric, adolescent, and young adult patients with non-DIPG grade 4 gliomas: a contemporary pooled institutional experience. J Neurooncol. 2023 Jul; 163(3):717-726.
Score: 0.069
-
Quantifying the risk and dosimetric variables of symptomatic brainstem injury after proton beam radiation in pediatric brain tumors. Neuro Oncol. 2022 09 01; 24(9):1571-1581.
Score: 0.065
-
Case series of diffuse extraneural metastasis in H3F3A mutant high-grade gliomas: Clinical, molecular phenotype and literature review. J Clin Neurosci. 2021 Jul; 89:405-411.
Score: 0.060
-
Patterns of care for pediatric patients with newly-diagnosed grade II gliomas. Childs Nerv Syst. 2021 05; 37(5):1563-1572.
Score: 0.058
-
Dual inhibition of BRAF and mTOR in BRAFV600E -mutant pediatric, adolescent, and young adult brain tumors. Cold Spring Harb Mol Case Stud. 2020 08; 6(4).
Score: 0.057
-
Phase I study of intraventricular infusions of autologous ex vivo expanded NK cells in children with recurrent medulloblastoma and ependymoma. Neuro Oncol. 2020 08 17; 22(8):1214-1225.
Score: 0.057
-
Pediatric high-grade glioma: aberrant epigenetics and kinase signaling define emerging therapeutic opportunities. J Neurooncol. 2020 Oct; 150(1):17-26.
Score: 0.056
-
Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201. J Neurooncol. 2019 Oct; 145(1):97-105.
Score: 0.053
-
Extending the Neuroanatomic Territory of Diffuse Midline Glioma, K27M Mutant: Pineal Region Origin. Pediatr Neurosurg. 2018; 53(1):59-63.
Score: 0.047